OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Liposomes, transfersomes and niosomes: production methods and their applications in the vaccinal field
Domenico Riccardi, Lucia Baldino, Ernesto Reverchon
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 15

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 9

mRNA vaccines in the context of cancer treatment: from concept to application
Qiang Fu, Xiaoming Zhao, Jinxia Hu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Medicine Meets Science: The Imperative of Scientific Research and Publishing for Physician-Scientists
Sonu Bhaskar
Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging (2025) Vol. 35, Iss. S 01, pp. S9-S17
Open Access

Antitumor mRNA vaccines based on neoantigens
Ekaterina V. Starostina, L. F. Nizolenko, Larisa I. Karpenko, et al.
Siberian Journal of Oncology (2025) Vol. 23, Iss. 6, pp. 149-158
Open Access

The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access

Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy
Saber İmani, Xiaoyan Li, Keyi Chen, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access

Advances in mRNA-Based Cancer Vaccines
Ling Ni
Vaccines (2023) Vol. 11, Iss. 10, pp. 1599-1599
Open Access | Times Cited: 15

Perspectives in the Development of Tools to Assess Vaccine Literacy
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 422-422
Open Access | Times Cited: 4

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
Alexey D. Perenkov, Alena D. Sergeeva, Maria V. Vedunova, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1600-1600
Open Access | Times Cited: 10

Deciphering the Immunogenicity of Monkeypox Proteins for Designing the Potential mRNA Vaccine
Mohibullah Shah, Samavia Jaan, Muhammad Shehroz, et al.
ACS Omega (2023) Vol. 8, Iss. 45, pp. 43341-43355
Open Access | Times Cited: 8

Delta Variant in the COVID-19 Pandemic: A Comparative Study on Clinical Outcomes Based on Vaccination Status
Damiana-Maria Vulturar, Liviu-Ștefan Moacă, Maria Adriana Neag, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 358-358
Open Access | Times Cited: 2

Expanding the RNA polymerase biocatalyst solution space for mRNA manufacture
Edward Curry, Svetlana E. Sedelnikova, John B. Rafferty, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 6
Open Access | Times Cited: 2

Advancement in the development of mRNA‐based vaccines for respiratory viruses
Tays Troncoso-Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 2

Breaking Barriers: A Future Perspective on Glioblastoma Therapy with mRNA-Based Immunotherapies and Oncolytic Viruses
Alexandro Guterres, Paulo Niemeyer Filho, Vivaldo Moura‐Neto
Vaccines (2024) Vol. 12, Iss. 1, pp. 61-61
Open Access | Times Cited: 1

Development of Tools to Assess Vaccine Literacy: A Scoping Review and Future Perspectives
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, et al.
(2024)
Open Access | Times Cited: 1

Development of Tools to Assess Vaccine Literacy: A Scoping Review and Future Perspectives
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, et al.
(2024)
Open Access | Times Cited: 1

Innovative Strategies to Enhance mRNA Vaccine Delivery and Effectiveness: Mechanisms and Future Outlook
Abhishek Verma, Ankit Awasthi
Current Pharmaceutical Design (2024) Vol. 30, Iss. 14, pp. 1049-1059
Closed Access | Times Cited: 1

mRNA vaccines: a new era in vaccine development
Shubhra Chandra, Jennifer C Wilson, David M. Good, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 10, pp. 1543-1564
Open Access | Times Cited: 1

Bioinformatics-Driven mRNA-Based Vaccine Design for Controlling Tinea Cruris Induced by Trichophyton rubrum
Amir Elalouf, Hanan Maoz, Amit Yaniv Rosenfeld
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 983-983
Open Access | Times Cited: 1

LEVERAGING THE SUCCESS OF MRNA LIPID NANOPARTICLE VACCINE IN COVID-19 TREATMENT: A NARRATIVE REVIEW ON ITS POTENTIAL APPLICATION IN MALARIA TREATMENT
Franklyn Nonso Iheagwam, ENIOLA DEBORAH ADEDOYIN
International Journal of Applied Pharmaceutics (2024), pp. 59-66
Open Access | Times Cited: 1

Expanding the RNA polymerase biocatalyst solution space for mRNA manufacture
Edward Curry, Svetlana E. Sedelnikova, John B. Rafferty, et al.
Authorea (Authorea) (2024)
Open Access

VDR mRNA Expression And Serum Vitamin D Levels in Post-Covid Vaccinated Patients
Sandesh Shende, Jaishriram Rathored
F1000Research (2024) Vol. 13, pp. 349-349
Open Access

Page 1 - Next Page

Scroll to top